Join us for our Symposium, “Is it time for Evidence-based Cytopathology?”, on Monday, June 17th, 2024, at 2 pm CET!
Epistudia, in collaboration with the
Journal of Cytopathology and it`s Editor in Chief, Dr. Philippe Vielh, is organizing a Zoom webinar to discuss the current challenges in cytopathology research. Featuring guest speakers who specialize in systematic reviews, meta-analysis, and evidence-based medicine, this symposium will offer new insights into implementing evidence-based practices in cytopathology. Don't miss this opportunity to be at the forefront of innovation in the field.
Purpose of the Event
The symposium "Is it time for Evidence-based Cytopathology?" aims to assess the feasibility and benefits of adopting an evidence-based approach in cytopathology practice. By bringing together experts, it seeks to explore how evidence-based principles can enhance diagnostic accuracy, patient outcomes, and healthcare delivery in this field.
Organizers: Epistudia in collaboration with the Journal of Cytopathology
Format: Zoom webinar
Date: June 17th, at 2PM CET
Topics: Is it time for Evidence-based Cytopathology?
Guest Speakers: Experts in cytopathology, systematic reviews, meta-analysis, and evidence-based medicine.
- Joshua JX LI, MD, Clinical Assistant Professor, Department of Pathology, The University of Hong Kong. "Research Challenges in Cytopathology".
- Sahar J. Farahani, MD, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. "Impact of implementing the First Edition of the Paris System for Reporting: a Systematic Review and Meta-Analyses.
- Taulant Muka, MD, PhD, PD, CEO of Epistudia. "The Bright, the Belighted, and the Bold: Meta-Analyses."
- Marija Glisic, MD, PhD, PD, Institute of Social and Preventive Medicine, University of Bern. "A Cherry on Top: The GRADE Framework for Clinical Practice Reccommendations."
Insights: Implementing evidence-based practices in cytopathology
